PRAX
Praxis Precision Medicines, Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
Praxis Precision Medicines (PRAX) Stock: Buy, Sell, or Hold?
$346.21
+8.62 (+2.55%)
β²
5d:
+21.57%
30d:
+42.27%
90d:
-6.04%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 09, 2026
0d
Protect PRAX Gains
Updated Nov 11, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (27%)
Quality Score
38/100
Position
EXTENDED
30-Day Fair Range
$247.52 β $300.57
Position: EXTENDED
Forward P/E & Valuation
-35.7x
Next 12M consensus est.
Wall Street Target
$676.20
+95.3% upside
Options IV & Volume
33th pct IV
HIGH volume confirmation
Support / Resistance
$260.77 / $351.64
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
βΈοΈ WAIT FOR BETTER ENTRY: PRAX is 15.2% above its trading range ($300.57). While momentum could continue, risk/reward favors waiting for a pullback.
Get Alerted When PRAX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: PRAX is currently trading at $346.21, which is considered extended relative to its 30-day fair value range of $247.52 to $300.57.
Technical Outlook: Technically, PRAX is in a downtrend. The price is approaching resistance at $351.64. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: PRAX scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $676.20 (+95.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PRAX is in a downtrend. The price is approaching resistance at $351.64. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: PRAX scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $676.20 (+95.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$247.52 -
$300.57
Company Quality Score
38/100
(SELL)
Options IV Signal
33th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
27.1%
Trading Range & Key Levels
30-Day Trading Range
$247.52 -
$300.57
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
Β±$44.40
(12.8%)
Support Level
$260.77
Resistance Level
$351.64
Current Trend
Downtrend
Technical data as of
Nov 11, 2026
Protect Your Profits
Holding PRAX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BEARISH: Price significantly overextended (+15.2% above its trading range)
- NEUTRAL: Options fairly priced (IV 33th percentile)
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 95.3% below Wall St target ($676.20)
- WARNING: Composite score 38/100 in the bottom quintile β this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-35.70
Wall Street Target
$676.20
(+95.3%)
Revenue Growth (YoY)
1349.1%
Share PRAX Analysis
Share this live PRAX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (PRAX)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 10, 2026
Daily AI digest
AI Retail Discussion Summary:
Bullish sentiment on StockTwits as HC Wainwright reiterated a Buy rating and $1201 price target for $PRAX. Praxis Precision Medicines' P/B ratio is higher than the industry average and peer group, indicating investors are paying a premium for the biotech stock.
Key Retail Themes:
Buy rating and price target from HC Wainwright
Praxis Precision Medicines' P/B ratio vs industry and peer groups
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 1:17 AM ET
Data refreshes hourly during market hours. Next update: 2:17 AM
Data refreshes hourly during market hours. Next update: 2:17 AM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PRAX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RVMD
Revolution Medicines Inc |
STRONG BUY
25 analysts |
$261 | 53 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
21 analysts |
$95 | 41 HOLD |
|
JANX
Janux Therapeutics Inc |
STRONG BUY
18 analysts |
$32 | 51 HOLD |
|
SNDX
Syndax Pharmaceuticals I⦠|
STRONG BUY
12 analysts |
$35 | 60 HOLD |
|
ACHV
Achieve Life Sciences Inc |
STRONG BUY
12 analysts |
$14 | 56 HOLD |
Advanced PRAX Option Strategies
Professional options setups generated by AI based on today's PRAX price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive PRAX Research Pages